Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Histology independent drug development - Is this the future for cancer drugs?
Billingham L, Brown L, Framke T, Greystoke A, Hovig E, Mathur S, Page P, Pean E, Barjesteh van Waalwijk van Doorn-Khosrovani S, Vonk R, Wissink S, Zander H, Plummer R. Billingham L, et al. Among authors: greystoke a. Cancer Treat Rev. 2024 Feb;123:102674. doi: 10.1016/j.ctrv.2023.102674. Epub 2023 Dec 23. Cancer Treat Rev. 2024. PMID: 38176220 Free article. Review.
The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato-oncology inpatients: A cohort study.
Welford J, Rafferty R, Hunt K, Short D, Duncan L, Ward A, Rushton C, Todd A, Nair S, Hoather T, Clarke M, Dawes L, Anderson V, Pelham A, Lowe H, Dewhurst F, Greystoke A. Welford J, et al. Among authors: greystoke a. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13752. doi: 10.1111/ecc.13752. Epub 2022 Oct 26. Eur J Cancer Care (Engl). 2022. PMID: 36286099 Free PMC article.
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.
Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Chénard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC, Banerji U, Plummer R. Halford S, et al. Among authors: greystoke a. Clin Cancer Res. 2023 Apr 14;29(8):1429-1439. doi: 10.1158/1078-0432.CCR-22-2263. Clin Cancer Res. 2023. PMID: 36652553 Free PMC article. Clinical Trial.
Social determinants of health inequalities in early phase clinical trials in Northern England.
Rae S, Shaya S, Taylor E, Hoben J, Oluwashegun D, Lowe H, Haris N, Bashir S, Oing C, Krebs MG, Thistlethwaite FC, Carter L, Cook N, Greystoke A, Graham DM, Plummer R. Rae S, et al. Among authors: greystoke a. Br J Cancer. 2024 Sep;131(4):685-691. doi: 10.1038/s41416-024-02765-w. Epub 2024 Jun 24. Br J Cancer. 2024. PMID: 38914804 Free PMC article.
Prevalence of mutations in common tumour types in Northern England and comparable utility of national and international Trial Finders.
Rae S, Plummer E, Fitzgerald L, Hogarth L, Bridgewood A, Brown-Schofield L, Graham J, Haigh S, McAnulty C, Drew Y, Haris N, Bashir S, Plummer R, Greystoke A. Rae S, et al. Among authors: greystoke a. J Cancer Res Clin Oncol. 2023 Dec;149(18):16355-16363. doi: 10.1007/s00432-023-05365-y. Epub 2023 Sep 13. J Cancer Res Clin Oncol. 2023. PMID: 37702806 Free PMC article.
110 results